(1-ethenylazirin-2-yl)-[[3-[5-[3-(hydroxymethyl)-1-oxo-3a,4-dihydro-3H-[1,3]oxazolo[4,3-c][1,4]benzoxazin-7-yl]-2-pyridinyl]-2-oxo-1,3-oxazolidin-5-yl]methoxy]phosphinic acid

C24H23N4O9P — CID 123340364

IUPAC(1-ethenylazirin-2-yl)-[[3-[5-[3-(hydroxymethyl)-1-oxo-3a,4-dihydro-3H-[1,3]oxazolo[4,3-c][1,4]benzoxazin-7-yl]-2-pyridinyl]-2-oxo-1,3-oxazolidin-5-yl]methoxy]phosphinic acid
SMILESC=CN1C=C1P(=O)(O)OCC1CN(c2ccc(-c3ccc4c(c3)OCC3C(CO)OC(=O)N43)cn2)C(=O)O1
InChIInChI=1S/C24H23N4O9P/c1-2-26-10-22(26)38(32,33)35-12-16-9-27(23(30)36-16)21-6-4-15(8-25-21)14-3-5-17-19(7-14)34-13-18-20(11-29)37-24(31)28(17)18/h2-8,10,16,18,20,29H,1,9,11-13H2,(H,32,33)
InChIKeyAVMLKPLZQHBGKQ-UHFFFAOYSA-N
MW542.44 g/mol
LogP2.61
Rot. Bonds8

About (1-ethenylazirin-2-yl)-[[3-[5-[3-(hydroxymethyl)-1-oxo-3a,4-dihydro-3H-[1,3]oxazolo[4,3-c][1,4]benzoxazin-7-yl]-2-pyridinyl]-2-oxo-1,3-oxazolidin-5-yl]methoxy]phosphinic acid

(1-ethenylazirin-2-yl)-[[3-[5-[3-(hydroxymethyl)-1-oxo-3a,4-dihydro-3H-[1,3]oxazolo[4,3-c][1,4]benzoxazin-7-yl]-2-pyridinyl]-2-oxo-1,3-oxazolidin-5-yl]methoxy]phosphinic acid (PubChem CID 123340364) has the molecular formula C24H23N4O9P and a molecular weight of 542.44 g/mol. Its IUPAC name is (1-ethenylazirin-2-yl)-[[3-[5-[3-(hydroxymethyl)-1-oxo-3a,4-dihydro-3H-[1,3]oxazolo[4,3-c][1,4]benzoxazin-7-yl]-2-pyridinyl]-2-oxo-1,3-oxazolidin-5-yl]methoxy]phosphinic acid.

Molecular Properties

Compound Name(1-ethenylazirin-2-yl)-[[3-[5-[3-(hydroxymethyl)-1-oxo-3a,4-dihydro-3H-[1,3]oxazolo[4,3-c][1,4]benzoxazin-7-yl]-2-pyridinyl]-2-oxo-1,3-oxazolidin-5-yl]methoxy]phosphinic acid
PubChem CID123340364
Molecular FormulaC24H23N4O9P
Molecular Weight542.44 g/mol
Exact Mass542.12
IUPAC Name(1-ethenylazirin-2-yl)-[[3-[5-[3-(hydroxymethyl)-1-oxo-3a,4-dihydro-3H-[1,3]oxazolo[4,3-c][1,4]benzoxazin-7-yl]-2-pyridinyl]-2-oxo-1,3-oxazolidin-5-yl]methoxy]phosphinic acid
SMILESC=CN1C=C1P(=O)(O)OCC1CN(c2ccc(-c3ccc4c(c3)OCC3C(CO)OC(=O)N43)cn2)C(=O)O1
InChIInChI=1S/C24H23N4O9P/c1-2-26-10-22(26)38(32,33)35-12-16-9-27(23(30)36-16)21-6-4-15(8-25-21)14-3-5-17-19(7-14)34-13-18-20(11-29)37-24(31)28(17)18/h2-8,10,16,18,20,29H,1,9,11-13H2,(H,32,33)
InChIKeyAVMLKPLZQHBGKQ-UHFFFAOYSA-N
XLogP2.61
TPSA150.97 Ų
H-Bond Donors2
H-Bond Acceptors10
Rotatable Bonds8
Heavy Atoms38
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500542.44
LogP ≤ 52.61
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phosphor', 'substructure': 'N/A'}

Analyze (1-ethenylazirin-2-yl)-[[3-[5-[3-(hydroxymethyl)-1-oxo-3a,4-dihydro-3H-[1,3]oxazolo[4,3-c][1,4]benzoxazin-7-yl]-2-pyridinyl]-2-oxo-1,3-oxazolidin-5-yl]methoxy]phosphinic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (1-ethenylazirin-2-yl)-[[3-[5-[3-(hydroxymethyl)-1-oxo-3a,4-dihydro-3H-[1,3]oxazolo[4,3-c][1,4]benzoxazin-7-yl]-2-pyridinyl]-2-oxo-1,3-oxazolidin-5-yl]methoxy]phosphinic acid?
The IUPAC name of (1-ethenylazirin-2-yl)-[[3-[5-[3-(hydroxymethyl)-1-oxo-3a,4-dihydro-3H-[1,3]oxazolo[4,3-c][1,4]benzoxazin-7-yl]-2-pyridinyl]-2-oxo-1,3-oxazolidin-5-yl]methoxy]phosphinic acid (CID 123340364) is (1-ethenylazirin-2-yl)-[[3-[5-[3-(hydroxymethyl)-1-oxo-3a,4-dihydro-3H-[1,3]oxazolo[4,3-c][1,4]benzoxazin-7-yl]-2-pyridinyl]-2-oxo-1,3-oxazolidin-5-yl]methoxy]phosphinic acid.
What is the SMILES notation for (1-ethenylazirin-2-yl)-[[3-[5-[3-(hydroxymethyl)-1-oxo-3a,4-dihydro-3H-[1,3]oxazolo[4,3-c][1,4]benzoxazin-7-yl]-2-pyridinyl]-2-oxo-1,3-oxazolidin-5-yl]methoxy]phosphinic acid?
The canonical SMILES for (1-ethenylazirin-2-yl)-[[3-[5-[3-(hydroxymethyl)-1-oxo-3a,4-dihydro-3H-[1,3]oxazolo[4,3-c][1,4]benzoxazin-7-yl]-2-pyridinyl]-2-oxo-1,3-oxazolidin-5-yl]methoxy]phosphinic acid is C=CN1C=C1P(=O)(O)OCC1CN(c2ccc(-c3ccc4c(c3)OCC3C(CO)OC(=O)N43)cn2)C(=O)O1.
What is the InChIKey of (1-ethenylazirin-2-yl)-[[3-[5-[3-(hydroxymethyl)-1-oxo-3a,4-dihydro-3H-[1,3]oxazolo[4,3-c][1,4]benzoxazin-7-yl]-2-pyridinyl]-2-oxo-1,3-oxazolidin-5-yl]methoxy]phosphinic acid?
The InChIKey is AVMLKPLZQHBGKQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H23N4O9P/c1-2-26-10-22(26)38(32,33)35-12-16-9-27(23(30)36-16)21-6-4-15(8-25-21)14-3-5-17-19(7-14)34-13-18-20(11-29)37-24(31)28(17)18/h2-8,10,16,18,20,29H,1,9,11-13H2,(H,32,33).
What are the key properties of (1-ethenylazirin-2-yl)-[[3-[5-[3-(hydroxymethyl)-1-oxo-3a,4-dihydro-3H-[1,3]oxazolo[4,3-c][1,4]benzoxazin-7-yl]-2-pyridinyl]-2-oxo-1,3-oxazolidin-5-yl]methoxy]phosphinic acid?
(1-ethenylazirin-2-yl)-[[3-[5-[3-(hydroxymethyl)-1-oxo-3a,4-dihydro-3H-[1,3]oxazolo[4,3-c][1,4]benzoxazin-7-yl]-2-pyridinyl]-2-oxo-1,3-oxazolidin-5-yl]methoxy]phosphinic acid has a molecular weight of 542.44 g/mol, XLogP of 2.61, 8 rotatable bonds, 2 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for (1-ethenylazirin-2-yl)-[[3-[5-[3-(hydroxymethyl)-1-oxo-3a,4-dihydro-3H-[1,3]oxazolo[4,3-c][1,4]benzoxazin-7-yl]-2-pyridinyl]-2-oxo-1,3-oxazolidin-5-yl]methoxy]phosphinic acid is sourced from PubChem (CID 123340364), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).